0001415889-19-000660.txt : 20190605 0001415889-19-000660.hdr.sgml : 20190605 20190605160515 ACCESSION NUMBER: 0001415889-19-000660 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190603 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASEY MICHAEL D CENTRAL INDEX KEY: 0001190435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 19879740 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-06052019_040602.xml X0306 4 2019-06-03 0000816284 CELGENE CORP /DE/ CELG 0001190435 CASEY MICHAEL D C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 true false false false Common Stock 2019-06-03 4 M 0 24666 22.47 A 24666 D Common Stock 117813 I By Family Trust Restricted Stock Unit 2019-06-03 4 A 0 4756 0 A Common Stock 4756 4756 D Stock Option (right to buy) 22.47 2019-06-03 4 M 0 24666 0 D 2019-06-17 Common Stock 24666 0 D The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022. Vested shares will be delivered to the reporting person promptly after the vesting date. The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. The option was fully exercisable. The option was issued pursuant to the Company's 2008 Stock Incentive Plan. /s/ Mark J. Alles, Attorney-in-Fact 2019-06-05 EX-24 2 ex24-06052019_040602.htm ex24-06052019_040602.htm

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark J. Alles, David V. Elkins, Jonathan P. Biller and Alexis M. Pinto the undersigned’s true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Celgene Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of April, 2019.

/s/ Michael D. Casey

Name: Michael D. Casey